fanta.bio Sample: CNhs11860
23847 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1419 / 17959 (7.9%) | 372 / 179590 (0.2%) | −324.0 | −324.0 | 38.15 |
| TP53 SRX19538267 | U2OS Bone | 453 / 17959 (2.5%) | 135 / 179590 (0.1%) | −324.0 | −324.0 | 33.56 |
| TP53 SRX19538268 | U2OS Bone | 503 / 17959 (2.8%) | 157 / 179590 (0.1%) | −324.0 | −324.0 | 32.04 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 549 / 17959 (3.1%) | 178 / 179590 (0.1%) | −324.0 | −324.0 | 30.84 |
| TP53 SRX19538274 | U2OS Bone | 494 / 17959 (2.8%) | 162 / 179590 (0.1%) | −324.0 | −324.0 | 30.49 |
| TP53 SRX19538273 | U2OS Bone | 441 / 17959 (2.5%) | 147 / 179590 (0.1%) | −324.0 | −324.0 | 30.00 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 2023 / 17959 (11.3%) | 690 / 179590 (0.4%) | −324.0 | −324.0 | 29.32 |
| TP53 SRX19538276 | U2OS Bone | 496 / 17959 (2.8%) | 170 / 179590 (0.1%) | −324.0 | −324.0 | 29.18 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2075 / 17959 (11.6%) | 727 / 179590 (0.4%) | −324.0 | −324.0 | 28.54 |
| SCML2 SRX644728 | 293 Kidney | 1811 / 17959 (10.1%) | 659 / 179590 (0.4%) | −324.0 | −324.0 | 27.48 |
| HIF1A SRX11007095 | HK-2 Kidney | 2503 / 17959 (13.9%) | 931 / 179590 (0.5%) | −324.0 | −324.0 | 26.89 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2873 / 17959 (16.0%) | 1127 / 179590 (0.6%) | −324.0 | −324.0 | 25.49 |
| FOXP1 SRX736067 | LNCAP Prostate | 2449 / 17959 (13.6%) | 978 / 179590 (0.5%) | −324.0 | −324.0 | 25.04 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2795 / 17959 (15.6%) | 1117 / 179590 (0.6%) | −324.0 | −324.0 | 25.02 |
| TP53 SRX19538280 | Osteoblasts Bone | 490 / 17959 (2.7%) | 200 / 179590 (0.1%) | −324.0 | −324.0 | 24.50 |
| TP53 SRX19538279 | Osteoblasts Bone | 610 / 17959 (3.4%) | 273 / 179590 (0.2%) | −324.0 | −324.0 | 22.34 |
| HIF1A SRX20663235 | HK-2 Kidney | 570 / 17959 (3.2%) | 264 / 179590 (0.1%) | −324.0 | −324.0 | 21.59 |
| MYH11 SRX265221 | ME-1 Blood | 1107 / 17959 (6.2%) | 556 / 179590 (0.3%) | −324.0 | −324.0 | 19.91 |
| TP53 SRX19538281 | Osteoblasts Bone | 521 / 17959 (2.9%) | 303 / 179590 (0.2%) | −324.0 | −324.0 | 17.19 |
| MED1 SRX9419945 | BT-474 Breast | 4051 / 17959 (22.6%) | 2828 / 179590 (1.6%) | −324.0 | −324.0 | 14.32 |
| MED1 SRX9419944 | BT-474 Breast | 3954 / 17959 (22.0%) | 2788 / 179590 (1.6%) | −324.0 | −324.0 | 14.18 |
| BRD4 SRX9419935 | BT-474 Breast | 3957 / 17959 (22.0%) | 2856 / 179590 (1.6%) | −324.0 | −324.0 | 13.86 |
| MED1 SRX9419946 | BT-474 Breast | 4102 / 17959 (22.8%) | 2991 / 179590 (1.7%) | −324.0 | −324.0 | 13.71 |
| BRD4 SRX9419938 | BT-474 Breast | 4053 / 17959 (22.6%) | 2989 / 179590 (1.7%) | −324.0 | −324.0 | 13.56 |
| BRD4 SRX9419936 | BT-474 Breast | 4069 / 17959 (22.7%) | 3007 / 179590 (1.7%) | −324.0 | −324.0 | 13.53 |
| BRD4 SRX9419937 | BT-474 Breast | 3923 / 17959 (21.8%) | 2904 / 179590 (1.6%) | −324.0 | −324.0 | 13.51 |
| MED1 SRX9419947 | BT-474 Breast | 3969 / 17959 (22.1%) | 2968 / 179590 (1.7%) | −324.0 | −324.0 | 13.37 |
| EZH2 SRX2146136 | LNCAP Prostate | 9201 / 17959 (51.2%) | 8168 / 179590 (4.5%) | −324.0 | −324.0 | 11.26 |
| BRD4 SRX736201 | 90-8TL Neural | 6974 / 17959 (38.8%) | 6731 / 179590 (3.7%) | −324.0 | −324.0 | 10.36 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 796 / 17959 (4.4%) | 967 / 179590 (0.5%) | −324.0 | −324.0 | 8.23 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2158 / 17959 (12.0%) | 2770 / 179590 (1.5%) | −324.0 | −324.0 | 7.79 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1453 / 17959 (8.1%) | 3926 / 179590 (2.2%) | −324.0 | −324.0 | 3.70 |
| TP53 SRX19538275 | U2OS Bone | 447 / 17959 (2.5%) | 163 / 179590 (0.1%) | −321.9 | −318.9 | 27.42 |
| TP53 SRX19538269 | U2OS Bone | 553 / 17959 (3.1%) | 444 / 179590 (0.2%) | −301.2 | −298.2 | 12.46 |
| AR SRX10820653 | LNCAP Prostate | 425 / 17959 (2.4%) | 169 / 179590 (0.1%) | −298.8 | −295.8 | 25.15 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1663 / 17959 (9.3%) | 5408 / 179590 (3.0%) | −297.0 | −294.0 | 3.08 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 738 / 17959 (4.1%) | 1060 / 179590 (0.6%) | −289.9 | −286.9 | 6.96 |
| Epitope tags SRX10549776 | K-562 Blood | 1635 / 17959 (9.1%) | 5393 / 179590 (3.0%) | −285.8 | −282.9 | 3.03 |
| BRD4 SRX736204 | 90-8TL Neural | 1156 / 17959 (6.4%) | 2958 / 179590 (1.6%) | −275.3 | −272.4 | 3.91 |
| AGO2 SRX4708039 | Hep G2 Liver | 2038 / 17959 (11.3%) | 7988 / 179590 (4.4%) | −274.4 | −271.5 | 2.55 |
| TP53 SRX19538270 | U2OS Bone | 514 / 17959 (2.9%) | 436 / 179590 (0.2%) | −272.7 | −269.8 | 11.79 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 685 / 17959 (3.8%) | 984 / 179590 (0.5%) | −268.8 | −265.9 | 6.96 |
| AR SRX10820651 | LNCAP Prostate | 444 / 17959 (2.5%) | 288 / 179590 (0.2%) | −264.6 | −261.7 | 15.42 |
| TP53 SRX19538282 | Osteoblasts Bone | 448 / 17959 (2.5%) | 307 / 179590 (0.2%) | −261.2 | −258.3 | 14.59 |
| PBX4 SRX2731658 | PC-3 Prostate | 1232 / 17959 (6.9%) | 28129 / 179590 (15.7%) | −259.8 | −257.0 | 0.44 |
| KAT7 SRX101303 | RKO Digestive tract | 1558 / 17959 (8.7%) | 5366 / 179590 (3.0%) | −255.1 | −252.2 | 2.90 |
| BRD1 SRX286203 | RKO Digestive tract | 1373 / 17959 (7.6%) | 4318 / 179590 (2.4%) | −254.9 | −252.0 | 3.18 |
| ESR1 SRX7624157 | MCF-7 Breast | 833 / 17959 (4.6%) | 22093 / 179590 (12.3%) | −252.1 | −249.2 | 0.38 |
| IRF3 SRX11453858 | Hep G2 Liver | 318 / 17959 (1.8%) | 79 / 179590 (0.0%) | −250.7 | −247.9 | 40.25 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 971 / 17959 (5.4%) | 2327 / 179590 (1.3%) | −247.3 | −244.5 | 4.17 |
| ESR1 SRX4367193 | MCF-7 Breast | 1075 / 17959 (6.0%) | 25451 / 179590 (14.2%) | −247.1 | −244.3 | 0.42 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1104 / 17959 (6.1%) | 25828 / 179590 (14.4%) | −246.3 | −243.5 | 0.43 |
| ESR1 SRX371469 | MCF-7 Breast | 305 / 17959 (1.7%) | 13159 / 179590 (7.3%) | −242.8 | −240.1 | 0.23 |
| TP53 SRX19538271 | U2OS Bone | 727 / 17959 (4.0%) | 1302 / 179590 (0.7%) | −241.7 | −238.9 | 5.58 |
| FOXA1 SRX4815197 | MCF-7 Breast | 799 / 17959 (4.4%) | 21151 / 179590 (11.8%) | −239.6 | −236.9 | 0.38 |
| BMI1 SRX644729 | 293 Kidney | 323 / 17959 (1.8%) | 110 / 179590 (0.1%) | −236.8 | −234.0 | 29.36 |
| FOXA1 SRX176863 | MCF-7 Breast | 378 / 17959 (2.1%) | 14232 / 179590 (7.9%) | −234.9 | −232.1 | 0.27 |
| FOXA1 SRX176862 | MCF-7 Breast | 417 / 17959 (2.3%) | 14902 / 179590 (8.3%) | −234.6 | −231.9 | 0.28 |
| ESR1 SRX20282961 | MCF-7 Breast | 396 / 17959 (2.2%) | 14483 / 179590 (8.1%) | −232.7 | −230.0 | 0.27 |
| BRPF3 SRX796085 | RKO Digestive tract | 1213 / 17959 (6.8%) | 3720 / 179590 (2.1%) | −232.0 | −229.3 | 3.26 |
| ESR1 SRX371478 | MCF-7 Breast | 415 / 17959 (2.3%) | 14765 / 179590 (8.2%) | −231.3 | −228.5 | 0.28 |
| ESR1 SRX7624156 | MCF-7 Breast | 527 / 17959 (2.9%) | 16583 / 179590 (9.2%) | −229.8 | −227.1 | 0.32 |
| ESR1 SRX176861 | MCF-7 Breast | 547 / 17959 (3.0%) | 16893 / 179590 (9.4%) | −229.4 | −226.7 | 0.32 |
| ESR1 SRX176860 | MCF-7 Breast | 546 / 17959 (3.0%) | 16802 / 179590 (9.4%) | −227.2 | −224.4 | 0.32 |
| BRPF3 SRX796084 | RKO Digestive tract | 1663 / 17959 (9.3%) | 6436 / 179590 (3.6%) | −226.3 | −223.6 | 2.58 |
| ESR1 SRX20282960 | MCF-7 Breast | 365 / 17959 (2.0%) | 13649 / 179590 (7.6%) | −223.2 | −220.5 | 0.27 |
| FOXA1 SRX3931044 | MCF-7 Breast | 738 / 17959 (4.1%) | 19633 / 179590 (10.9%) | −222.5 | −219.8 | 0.38 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 305 / 17959 (1.7%) | 108 / 179590 (0.1%) | −221.3 | −218.6 | 28.24 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 543 / 17959 (3.0%) | 736 / 179590 (0.4%) | −221.3 | −218.6 | 7.38 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 477 / 17959 (2.7%) | 15432 / 179590 (8.6%) | −219.7 | −217.0 | 0.31 |
| FOXA1 SRX371481 | MCF-7 Breast | 346 / 17959 (1.9%) | 13202 / 179590 (7.4%) | −219.6 | −217.0 | 0.26 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 581 / 17959 (3.2%) | 17095 / 179590 (9.5%) | −219.2 | −216.6 | 0.34 |
| FOXA1 SRX1161177 | MCF-7 Breast | 330 / 17959 (1.8%) | 12849 / 179590 (7.2%) | −217.3 | −214.6 | 0.26 |
| ESR1 SRX20282939 | MCF-7 Breast | 379 / 17959 (2.1%) | 13626 / 179590 (7.6%) | −214.8 | −212.1 | 0.28 |
| IRF3 SRX11453861 | Hep G2 Liver | 279 / 17959 (1.6%) | 78 / 179590 (0.0%) | −214.5 | −211.8 | 35.77 |
| BRPF3 SRX796086 | RKO Digestive tract | 1577 / 17959 (8.8%) | 6121 / 179590 (3.4%) | −212.9 | −210.3 | 2.58 |
| ESR1 SRX371479 | MCF-7 Breast | 302 / 17959 (1.7%) | 12209 / 179590 (6.8%) | −212.9 | −210.2 | 0.25 |
| ING5 SRX286202 | RKO Digestive tract | 1463 / 17959 (8.1%) | 5420 / 179590 (3.0%) | −212.8 | −210.2 | 2.70 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 395 / 17959 (2.2%) | 13830 / 179590 (7.7%) | −212.6 | −209.9 | 0.29 |
| ESR1 SRX371467 | MCF-7 Breast | 351 / 17959 (2.0%) | 13003 / 179590 (7.2%) | −210.4 | −207.8 | 0.27 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 407 / 17959 (2.3%) | 13914 / 179590 (7.7%) | −208.8 | −206.2 | 0.29 |
| FOXA1 SRX371483 | MCF-7 Breast | 395 / 17959 (2.2%) | 13706 / 179590 (7.6%) | −208.6 | −206.0 | 0.29 |
| GATA3 SRX190239 | MCF-7 Breast | 515 / 17959 (2.9%) | 15657 / 179590 (8.7%) | −207.6 | −205.0 | 0.33 |
| ESR1 SRX194569 | MCF-7 Breast | 355 / 17959 (2.0%) | 12982 / 179590 (7.2%) | −207.4 | −204.8 | 0.27 |
| ESR1 SRX1531791 | MCF-7 Breast | 326 / 17959 (1.8%) | 12439 / 179590 (6.9%) | −206.4 | −203.8 | 0.26 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 515 / 17959 (2.9%) | 15558 / 179590 (8.7%) | −204.8 | −202.2 | 0.33 |
| TLE3 SRX4815191 | MCF-7 Breast | 334 / 17959 (1.9%) | 12521 / 179590 (7.0%) | −204.5 | −201.9 | 0.27 |
| ESR1 SRX371476 | MCF-7 Breast | 246 / 17959 (1.4%) | 10909 / 179590 (6.1%) | −204.1 | −201.5 | 0.23 |
| FOXA1 SRX1161176 | MCF-7 Breast | 331 / 17959 (1.8%) | 12434 / 179590 (6.9%) | −203.3 | −200.7 | 0.27 |
| ESR1 SRX20282972 | MCF-7 Breast | 385 / 17959 (2.1%) | 13365 / 179590 (7.4%) | −203.2 | −200.6 | 0.29 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 586 / 17959 (3.3%) | 1003 / 179590 (0.6%) | −201.7 | −199.2 | 5.84 |
| ESR1 SRX371468 | MCF-7 Breast | 205 / 17959 (1.1%) | 10030 / 179590 (5.6%) | −200.9 | −198.3 | 0.20 |
| ESR1 SRX10365535 | MCF-7 Breast | 264 / 17959 (1.5%) | 11129 / 179590 (6.2%) | −200.0 | −197.5 | 0.24 |
| ESR1 SRX20282954 | MCF-7 Breast | 381 / 17959 (2.1%) | 13193 / 179590 (7.3%) | −200.0 | −197.4 | 0.29 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 340 / 17959 (1.9%) | 12432 / 179590 (6.9%) | −198.3 | −195.8 | 0.27 |
| FOXA1 SRX371482 | MCF-7 Breast | 533 / 17959 (3.0%) | 15620 / 179590 (8.7%) | −198.2 | −195.6 | 0.34 |
| ESR1 SRX10365536 | MCF-7 Breast | 161 / 17959 (0.9%) | 9058 / 179590 (5.0%) | −197.8 | −195.3 | 0.18 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 466 / 17959 (2.6%) | 14404 / 179590 (8.0%) | −193.9 | −191.3 | 0.32 |
| STAT5B SRX831881 | CD8+ T cells Blood | 287 / 17959 (1.6%) | 133 / 179590 (0.1%) | −192.7 | −190.2 | 21.58 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 273 / 17959 (1.5%) | 11048 / 179590 (6.2%) | −192.0 | −189.5 | 0.25 |
| FOXA1 SRX100454 | T-47D Breast | 473 / 17959 (2.6%) | 14452 / 179590 (8.0%) | −192.0 | −189.5 | 0.33 |
| ESR1 SRX194572 | MCF-7 Breast | 215 / 17959 (1.2%) | 9960 / 179590 (5.5%) | −191.8 | −189.3 | 0.22 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 515 / 17959 (2.9%) | 801 / 179590 (0.4%) | −190.6 | −188.1 | 6.43 |
| ESR1 SRX4367192 | MCF-7 Breast | 764 / 17959 (4.3%) | 18825 / 179590 (10.5%) | −189.5 | −187.0 | 0.41 |
| ESR1 SRX371470 | ZR-75-1 Breast | 333 / 17959 (1.9%) | 12030 / 179590 (6.7%) | −189.3 | −186.8 | 0.28 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 269 / 17959 (1.5%) | 10885 / 179590 (6.1%) | −189.1 | −186.6 | 0.25 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 683 / 17959 (3.8%) | 1503 / 179590 (0.8%) | −188.7 | −186.2 | 4.54 |
| FOXA1 SRX1161173 | MCF-7 Breast | 290 / 17959 (1.6%) | 11247 / 179590 (6.3%) | −188.6 | −186.1 | 0.26 |
| RAC1 SRX10365543 | MCF-7 Breast | 175 / 17959 (1.0%) | 9079 / 179590 (5.1%) | −188.4 | −185.9 | 0.19 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 986 / 17959 (5.5%) | 21951 / 179590 (12.2%) | −188.2 | −185.7 | 0.45 |
| ESR1 SRX20282955 | MCF-7 Breast | 378 / 17959 (2.1%) | 12755 / 179590 (7.1%) | −188.1 | −185.6 | 0.30 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1119 / 17959 (6.2%) | 23785 / 179590 (13.2%) | −188.0 | −185.5 | 0.47 |
| AGO2 SRX6783958 | Hep G2 Liver | 1278 / 17959 (7.1%) | 4691 / 179590 (2.6%) | −187.9 | −185.4 | 2.72 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 831 / 17959 (4.6%) | 19718 / 179590 (11.0%) | −187.4 | −184.9 | 0.42 |
| ESR1 SRX20282973 | MCF-7 Breast | 444 / 17959 (2.5%) | 13817 / 179590 (7.7%) | −187.0 | −184.5 | 0.32 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 336 / 17959 (1.9%) | 11991 / 179590 (6.7%) | −186.6 | −184.1 | 0.28 |
| FOXA1 SRX1161175 | MCF-7 Breast | 269 / 17959 (1.5%) | 10780 / 179590 (6.0%) | −185.7 | −183.2 | 0.25 |
| NFYB SRX16608147 | HeLa Uterus | 301 / 17959 (1.7%) | 180 / 179590 (0.1%) | −185.1 | −182.6 | 16.72 |
| ESR1 SRX2881002 | MCF-7 Breast | 337 / 17959 (1.9%) | 11940 / 179590 (6.6%) | −184.3 | −181.9 | 0.28 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 665 / 17959 (3.7%) | 1460 / 179590 (0.8%) | −184.1 | −181.6 | 4.55 |
| FOXA1 SRX371480 | MCF-7 Breast | 247 / 17959 (1.4%) | 10328 / 179590 (5.8%) | −184.0 | −181.5 | 0.24 |
| TP53 SRX19538272 | U2OS Bone | 608 / 17959 (3.4%) | 1213 / 179590 (0.7%) | −183.9 | −181.5 | 5.01 |
| ESR1 SRX371471 | ZR-75-1 Breast | 419 / 17959 (2.3%) | 13291 / 179590 (7.4%) | −183.6 | −181.1 | 0.32 |
| ESR1 SRX371477 | MCF-7 Breast | 163 / 17959 (0.9%) | 8691 / 179590 (4.8%) | −183.4 | −181.0 | 0.19 |
| ARID1A SRX5089376 | MCF-7 Breast | 315 / 17959 (1.8%) | 11527 / 179590 (6.4%) | −183.4 | −180.9 | 0.27 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 340 / 17959 (1.9%) | 11928 / 179590 (6.6%) | −182.3 | −179.9 | 0.29 |
| ESR1 SRX2881000 | MCF-7 Breast | 314 / 17959 (1.7%) | 11475 / 179590 (6.4%) | −182.2 | −179.8 | 0.27 |
| AGO2 SRX6783957 | Hep G2 Liver | 1286 / 17959 (7.2%) | 4845 / 179590 (2.7%) | −181.2 | −178.8 | 2.65 |
| GATA3 SRX5057632 | MCF-7 Breast | 237 / 17959 (1.3%) | 10027 / 179590 (5.6%) | −180.2 | −177.8 | 0.24 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 374 / 17959 (2.1%) | 12429 / 179590 (6.9%) | −180.0 | −177.6 | 0.30 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1214 / 17959 (6.8%) | 4434 / 179590 (2.5%) | −179.7 | −177.3 | 2.74 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 341 / 17959 (1.9%) | 11835 / 179590 (6.6%) | −179.0 | −176.6 | 0.29 |
| CDK9 SRX7366783 | MCF-7 Breast | 273 / 17959 (1.5%) | 137 / 179590 (0.1%) | −178.6 | −176.2 | 19.93 |
| ESR1 SRX2943591 | MCF-7 Breast | 255 / 17959 (1.4%) | 10312 / 179590 (5.7%) | −178.6 | −176.2 | 0.25 |
| ESR1 SRX20282940 | MCF-7 Breast | 411 / 17959 (2.3%) | 12965 / 179590 (7.2%) | −177.6 | −175.2 | 0.32 |
| FOXA1 SRX1161174 | MCF-7 Breast | 393 / 17959 (2.2%) | 12649 / 179590 (7.0%) | −177.1 | −174.7 | 0.31 |
| SSRP1 SRX3436567 | HT-1080 Bone | 437 / 17959 (2.4%) | 597 / 179590 (0.3%) | −177.0 | −174.7 | 7.32 |
| ESR1 SRX330067 | MCF-7 Breast | 335 / 17959 (1.9%) | 11670 / 179590 (6.5%) | −177.0 | −174.7 | 0.29 |
| ESR1 SRX20282946 | MCF-7 Breast | 211 / 17959 (1.2%) | 9442 / 179590 (5.3%) | −177.0 | −174.6 | 0.22 |
| GATA3 SRX176864 | MCF-7 Breast | 279 / 17959 (1.6%) | 10685 / 179590 (5.9%) | −176.7 | −174.4 | 0.26 |
| RAC1 SRX10365541 | MCF-7 Breast | 191 / 17959 (1.1%) | 9045 / 179590 (5.0%) | −176.5 | −174.1 | 0.21 |
| AR SRX9469988 | LAPC-4 Prostate | 511 / 17959 (2.8%) | 14486 / 179590 (8.1%) | −175.3 | −172.9 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 390 / 17959 (2.2%) | 12510 / 179590 (7.0%) | −174.4 | −172.0 | 0.31 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 886 / 17959 (4.9%) | 19974 / 179590 (11.1%) | −173.8 | −171.4 | 0.44 |
| ESR1 SRX10365532 | MCF-7 Breast | 194 / 17959 (1.1%) | 9020 / 179590 (5.0%) | −173.6 | −171.2 | 0.22 |
| YAP1 SRX5718140 | 293 Kidney | 665 / 17959 (3.7%) | 16763 / 179590 (9.3%) | −173.3 | −171.0 | 0.40 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 647 / 17959 (3.6%) | 16488 / 179590 (9.2%) | −173.2 | −170.9 | 0.39 |
| TLE3 SRX4815192 | MCF-7 Breast | 346 / 17959 (1.9%) | 11734 / 179590 (6.5%) | −173.2 | −170.9 | 0.29 |
| FOXA1 SRX11222437 | MCF-7 Breast | 267 / 17959 (1.5%) | 10331 / 179590 (5.8%) | −172.2 | −169.9 | 0.26 |
| TP53 SRX396254 | Fibroblasts Others | 925 / 17959 (5.2%) | 2883 / 179590 (1.6%) | −172.0 | −169.6 | 3.21 |
| ARID1A SRX5089379 | MCF-7 Breast | 384 / 17959 (2.1%) | 12320 / 179590 (6.9%) | −171.7 | −169.3 | 0.31 |
| CDK9 SRX7366781 | MCF-7 Breast | 264 / 17959 (1.5%) | 135 / 179590 (0.1%) | −171.7 | −169.3 | 19.56 |
| FOXA1 SRX1787653 | MCF-7 Breast | 317 / 17959 (1.8%) | 11155 / 179590 (6.2%) | −170.6 | −168.3 | 0.28 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 273 / 17959 (1.5%) | 10377 / 179590 (5.8%) | −170.3 | −167.9 | 0.26 |
| FOS SRX150477 | MCF 10A Breast | 967 / 17959 (5.4%) | 20950 / 179590 (11.7%) | −169.7 | −167.4 | 0.46 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 349 / 17959 (1.9%) | 11671 / 179590 (6.5%) | −169.7 | −167.4 | 0.30 |
| ESR1 SRX10365558 | MCF-7 Breast | 252 / 17959 (1.4%) | 9968 / 179590 (5.6%) | −169.3 | −166.9 | 0.25 |
| ESR1 SRX3110725 | MCF-7 Breast | 345 / 17959 (1.9%) | 11580 / 179590 (6.4%) | −169.0 | −166.6 | 0.30 |
| FOXA1 SRX3931054 | MCF-7 Breast | 364 / 17959 (2.0%) | 11888 / 179590 (6.6%) | −168.7 | −166.4 | 0.31 |
| FOXA1 SRX3931043 | MCF-7 Breast | 402 / 17959 (2.2%) | 12510 / 179590 (7.0%) | −168.6 | −166.2 | 0.32 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1403 / 17959 (7.8%) | 26726 / 179590 (14.9%) | −168.3 | −165.9 | 0.52 |
| ESR1 SRX330069 | MCF-7 Breast | 229 / 17959 (1.3%) | 9503 / 179590 (5.3%) | −167.8 | −165.5 | 0.24 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 372 / 17959 (2.1%) | 11987 / 179590 (6.7%) | −167.7 | −165.4 | 0.31 |
| FOXA1 SRX3931055 | MCF-7 Breast | 329 / 17959 (1.8%) | 11259 / 179590 (6.3%) | −167.5 | −165.2 | 0.29 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 936 / 17959 (5.2%) | 20412 / 179590 (11.4%) | −167.2 | −164.9 | 0.46 |
| ESR1 SRX3123829 | MCF-7 Breast | 212 / 17959 (1.2%) | 9154 / 179590 (5.1%) | −166.7 | −164.4 | 0.23 |
| ESR1 SRX20282953 | MCF-7 Breast | 315 / 17959 (1.8%) | 10969 / 179590 (6.1%) | −165.9 | −163.6 | 0.29 |
| ESR1 SRX5323873 | MCF-7 Breast | 492 / 17959 (2.7%) | 13846 / 179590 (7.7%) | −165.5 | −163.2 | 0.36 |
| LEO1 SRX1873456 | SEM Blood | 1504 / 17959 (8.4%) | 6515 / 179590 (3.6%) | −165.0 | −162.7 | 2.31 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 318 / 17959 (1.8%) | 10970 / 179590 (6.1%) | −164.4 | −162.1 | 0.29 |
| ESR1 SRX20282971 | MCF-7 Breast | 391 / 17959 (2.2%) | 12181 / 179590 (6.8%) | −164.1 | −161.9 | 0.32 |
| NR2F2 SRX190293 | MCF-7 Breast | 421 / 17959 (2.3%) | 12666 / 179590 (7.1%) | −164.0 | −161.7 | 0.33 |
| YAP1 SRX757325 | H2052 Lung | 1038 / 17959 (5.8%) | 21682 / 179590 (12.1%) | −163.9 | −161.6 | 0.48 |
| FOXA1 SRX11222441 | MCF-7 Breast | 301 / 17959 (1.7%) | 10644 / 179590 (5.9%) | −163.3 | −161.0 | 0.28 |
| EP300 SRX176885 | MCF-7 Breast | 196 / 17959 (1.1%) | 8731 / 179590 (4.9%) | −162.7 | −160.4 | 0.22 |
| Epitope tags SRX10549778 | K-562 Blood | 1152 / 17959 (6.4%) | 4326 / 179590 (2.4%) | −162.6 | −160.3 | 2.66 |
| ESR1 SRX371475 | BT-474 Breast | 197 / 17959 (1.1%) | 8746 / 179590 (4.9%) | −162.5 | −160.2 | 0.23 |
| ESR1 SRX1012629 | MCF-7 Breast | 241 / 17959 (1.3%) | 9550 / 179590 (5.3%) | −162.2 | −160.0 | 0.25 |
| ESR1 SRX330070 | MCF-7 Breast | 198 / 17959 (1.1%) | 8753 / 179590 (4.9%) | −162.1 | −159.8 | 0.23 |
| TEAD1 SRX3401272 | MCF-7 Breast | 303 / 17959 (1.7%) | 10634 / 179590 (5.9%) | −161.9 | −159.7 | 0.28 |
| ESR1 SRX8537722 | MCF-7 Breast | 374 / 17959 (2.1%) | 11830 / 179590 (6.6%) | −161.9 | −159.7 | 0.32 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1375 / 17959 (7.7%) | 5745 / 179590 (3.2%) | −161.3 | −159.0 | 2.39 |
| ESR1 SRX20282938 | MCF-7 Breast | 316 / 17959 (1.8%) | 10834 / 179590 (6.0%) | −161.2 | −158.9 | 0.29 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 992 / 17959 (5.5%) | 20892 / 179590 (11.6%) | −160.0 | −157.8 | 0.47 |
| ESR1 SRX2943589 | MCF-7 Breast | 198 / 17959 (1.1%) | 8686 / 179590 (4.8%) | −159.8 | −157.6 | 0.23 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 909 / 17959 (5.1%) | 2951 / 179590 (1.6%) | −159.7 | −157.4 | 3.08 |
| KAT6A SRX20971022 | Fibroblasts Others | 230 / 17959 (1.3%) | 96 / 179590 (0.1%) | −159.5 | −157.3 | 23.96 |
| AR SRX9109110 | MDA-MB-453 Breast | 768 / 17959 (4.3%) | 17728 / 179590 (9.9%) | −159.3 | −157.0 | 0.43 |
| EP300 SRX1012648 | MCF-7 Breast | 183 / 17959 (1.0%) | 8373 / 179590 (4.7%) | −159.0 | −156.8 | 0.22 |
| MEAF6 DRX234811 | 293 Kidney | 1706 / 17959 (9.5%) | 8008 / 179590 (4.5%) | −158.8 | −156.6 | 2.13 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 381 / 17959 (2.1%) | 11826 / 179590 (6.6%) | −158.5 | −156.2 | 0.32 |
| ESR1 SRX371474 | BT-474 Breast | 182 / 17959 (1.0%) | 8336 / 179590 (4.6%) | −158.4 | −156.1 | 0.22 |
| Epitope tags DRX443510 | 293 Kidney | 1490 / 17959 (8.3%) | 6559 / 179590 (3.7%) | −158.2 | −155.9 | 2.27 |
| FOXA1 SRX5323843 | MCF-7 Breast | 201 / 17959 (1.1%) | 8687 / 179590 (4.8%) | −158.1 | −155.8 | 0.23 |
| MEAF6 DRX300417 | 293 Kidney | 1558 / 17959 (8.7%) | 7026 / 179590 (3.9%) | −157.6 | −155.4 | 2.22 |
| ESR1 SRX4451213 | MCF-7 Breast | 418 / 17959 (2.3%) | 12384 / 179590 (6.9%) | −157.2 | −155.0 | 0.34 |
| ESR1 SRX1469949 | MCF-7 Breast | 224 / 17959 (1.2%) | 9072 / 179590 (5.1%) | −156.6 | −154.4 | 0.25 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 233 / 17959 (1.3%) | 110 / 179590 (0.1%) | −155.6 | −153.4 | 21.18 |
| KAT7 DRX234808 | 293 Kidney | 797 / 17959 (4.4%) | 2392 / 179590 (1.3%) | −155.4 | −153.2 | 3.33 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 558 / 17959 (3.1%) | 1217 / 179590 (0.7%) | −155.3 | −153.1 | 4.59 |
| FOXA1 SRX028634 | MCF-7 Breast | 193 / 17959 (1.1%) | 8454 / 179590 (4.7%) | −155.2 | −153.0 | 0.23 |
| PGR SRX1012655 | MCF-7 Breast | 257 / 17959 (1.4%) | 9616 / 179590 (5.4%) | −155.2 | −152.9 | 0.27 |
| FOS SRX150478 | MCF 10A Breast | 1045 / 17959 (5.8%) | 21400 / 179590 (11.9%) | −155.0 | −152.8 | 0.49 |
| ESR1 SRX5323871 | MCF-7 Breast | 454 / 17959 (2.5%) | 12865 / 179590 (7.2%) | −154.6 | −152.4 | 0.35 |
| ESR1 SRX10365533 | MCF-7 Breast | 187 / 17959 (1.0%) | 8318 / 179590 (4.6%) | −154.6 | −152.4 | 0.22 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 293 / 17959 (1.6%) | 10200 / 179590 (5.7%) | −153.9 | −151.7 | 0.29 |
| GATA3 SRX6712581 | MCF-7 Breast | 347 / 17959 (1.9%) | 11110 / 179590 (6.2%) | −153.8 | −151.6 | 0.31 |
| FOXA1 SRX3931033 | MCF-7 Breast | 257 / 17959 (1.4%) | 9571 / 179590 (5.3%) | −153.7 | −151.5 | 0.27 |
| AR SRX1067071 | LHSAR Prostate | 825 / 17959 (4.6%) | 18289 / 179590 (10.2%) | −153.1 | −150.9 | 0.45 |
| ESR1 SRX11120903 | MCF-7 Breast | 360 / 17959 (2.0%) | 11289 / 179590 (6.3%) | −152.7 | −150.5 | 0.32 |
| FOXA1 SRX1787652 | MCF-7 Breast | 255 / 17959 (1.4%) | 9491 / 179590 (5.3%) | −152.4 | −150.2 | 0.27 |
| ESR1 SRX5323878 | MCF-7 Breast | 419 / 17959 (2.3%) | 12231 / 179590 (6.8%) | −152.3 | −150.1 | 0.34 |
| FOXA1 SRX3923516 | MCF-7 Breast | 297 / 17959 (1.7%) | 10204 / 179590 (5.7%) | −151.9 | −149.7 | 0.29 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 465 / 17959 (2.6%) | 12933 / 179590 (7.2%) | −151.7 | −149.5 | 0.36 |
| FOXA1 SRX11222442 | MCF-7 Breast | 279 / 17959 (1.6%) | 9892 / 179590 (5.5%) | −151.7 | −149.5 | 0.28 |
| FOXA1 SRX1787651 | MCF-7 Breast | 236 / 17959 (1.3%) | 9123 / 179590 (5.1%) | −151.3 | −149.1 | 0.26 |
| SSRP1 SRX3436566 | HT-1080 Bone | 328 / 17959 (1.8%) | 365 / 179590 (0.2%) | −150.9 | −148.7 | 8.99 |
| FOXA1 SRX3923517 | MCF-7 Breast | 296 / 17959 (1.6%) | 10154 / 179590 (5.7%) | −150.7 | −148.6 | 0.29 |
| FOXA2 SRX100448 | Hep G2 Liver | 468 / 17959 (2.6%) | 12912 / 179590 (7.2%) | −149.9 | −147.7 | 0.36 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 402 / 17959 (2.2%) | 11873 / 179590 (6.6%) | −149.9 | −147.7 | 0.34 |
| ESR1 SRX8537723 | MCF-7 Breast | 340 / 17959 (1.9%) | 10859 / 179590 (6.0%) | −149.8 | −147.6 | 0.31 |
| FOXA1 SRX100506 | Hep G2 Liver | 563 / 17959 (3.1%) | 14361 / 179590 (8.0%) | −149.8 | −147.6 | 0.39 |
| FOXA1 SRX1161203 | T-47D Breast | 303 / 17959 (1.7%) | 10231 / 179590 (5.7%) | −149.5 | −147.4 | 0.30 |
| FOXA1 SRX15430999 | T-47D Breast | 474 / 17959 (2.6%) | 12994 / 179590 (7.2%) | −149.5 | −147.3 | 0.36 |
| FOXA1 SRX1787655 | MCF-7 Breast | 210 / 17959 (1.2%) | 8591 / 179590 (4.8%) | −149.5 | −147.3 | 0.24 |
| FOXA1 SRX028635 | MCF-7 Breast | 207 / 17959 (1.2%) | 8535 / 179590 (4.8%) | −149.4 | −147.2 | 0.24 |
| FOXA2 SRX3230382 | Hep G2 Liver | 578 / 17959 (3.2%) | 14568 / 179590 (8.1%) | −149.2 | −147.1 | 0.40 |
| ESR1 SRX5323872 | MCF-7 Breast | 422 / 17959 (2.3%) | 12167 / 179590 (6.8%) | −149.2 | −147.1 | 0.35 |
| FOXA1 SRX1447317 | MCF-7 Breast | 275 / 17959 (1.5%) | 9725 / 179590 (5.4%) | −148.7 | −146.5 | 0.28 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 204 / 17959 (1.1%) | 8451 / 179590 (4.7%) | −148.6 | −146.4 | 0.24 |
| YAP1 SRX757326 | H2052 Lung | 920 / 17959 (5.1%) | 19419 / 179590 (10.8%) | −148.4 | −146.2 | 0.47 |
| FOXA1 SRX11222438 | MCF-7 Breast | 221 / 17959 (1.2%) | 8752 / 179590 (4.9%) | −148.1 | −146.0 | 0.25 |
| ESR1 SRX20282959 | MCF-7 Breast | 168 / 17959 (0.9%) | 7750 / 179590 (4.3%) | −147.8 | −145.7 | 0.22 |
| ESR1 SRX1012632 | MCF-7 Breast | 206 / 17959 (1.1%) | 8450 / 179590 (4.7%) | −147.2 | −145.1 | 0.24 |
| FOXA1 SRX3923518 | MCF-7 Breast | 293 / 17959 (1.6%) | 9984 / 179590 (5.6%) | −147.2 | −145.0 | 0.29 |
| 5-mC SRX882970 | LNCAP Prostate | 2764 / 17959 (15.4%) | 16194 / 179590 (9.0%) | −146.8 | −144.7 | 1.71 |
| ARID1A SRX5089382 | MCF-7 Breast | 302 / 17959 (1.7%) | 10122 / 179590 (5.6%) | −146.7 | −144.6 | 0.30 |
| AR SRX1067070 | LHSAR Prostate | 1032 / 17959 (5.7%) | 20862 / 179590 (11.6%) | −146.5 | −144.4 | 0.49 |
| ESR1 SRX5323877 | MCF-7 Breast | 332 / 17959 (1.8%) | 10619 / 179590 (5.9%) | −146.5 | −144.4 | 0.31 |
| EP300 SRX1012644 | MCF-7 Breast | 190 / 17959 (1.1%) | 8116 / 179590 (4.5%) | −146.0 | −143.9 | 0.23 |
| ARID1A SRX5089385 | MCF-7 Breast | 326 / 17959 (1.8%) | 10488 / 179590 (5.8%) | −145.7 | −143.5 | 0.31 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 809 / 17959 (4.5%) | 2580 / 179590 (1.4%) | −145.4 | −143.3 | 3.14 |
| FOXA1 SRX6878603 | LNCAP Prostate | 474 / 17959 (2.6%) | 12844 / 179590 (7.2%) | −145.3 | −143.2 | 0.37 |
| ESR1 SRX330068 | MCF-7 Breast | 200 / 17959 (1.1%) | 8273 / 179590 (4.6%) | −145.1 | −143.0 | 0.24 |
| ESR1 SRX4451212 | MCF-7 Breast | 412 / 17959 (2.3%) | 11858 / 179590 (6.6%) | −144.8 | −142.7 | 0.35 |
| ESR1 SRX5534831 | MCF-7 Breast | 334 / 17959 (1.9%) | 10592 / 179590 (5.9%) | −144.8 | −142.7 | 0.32 |
| FOXA1 SRX1961158 | T-47D Breast | 430 / 17959 (2.4%) | 12138 / 179590 (6.8%) | −144.8 | −142.7 | 0.35 |
| ESR1 SRX1012633 | MCF-7 Breast | 218 / 17959 (1.2%) | 8586 / 179590 (4.8%) | −144.7 | −142.5 | 0.25 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 356 / 17959 (2.0%) | 10946 / 179590 (6.1%) | −144.5 | −142.4 | 0.33 |
| FOXA1 SRX1961157 | T-47D Breast | 474 / 17959 (2.6%) | 12792 / 179590 (7.1%) | −143.9 | −141.7 | 0.37 |
| ESR1 SRX3110723 | MCF-7 Breast | 232 / 17959 (1.3%) | 8801 / 179590 (4.9%) | −143.4 | −141.3 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 294 / 17959 (1.6%) | 9867 / 179590 (5.5%) | −143.0 | −140.9 | 0.30 |
| ESR1 SRX1995229 | MCF-7 Breast | 434 / 17959 (2.4%) | 12134 / 179590 (6.8%) | −142.9 | −140.8 | 0.36 |
| ESR1 SRX1531796 | MCF-7 Breast | 230 / 17959 (1.3%) | 8748 / 179590 (4.9%) | −142.9 | −140.8 | 0.26 |
| FOXA1 SRX3923515 | MCF-7 Breast | 242 / 17959 (1.3%) | 8946 / 179590 (5.0%) | −142.4 | −140.3 | 0.27 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 641 / 17959 (3.6%) | 15230 / 179590 (8.5%) | −142.3 | −140.2 | 0.42 |
| FOXA1 SRX3931056 | MCF-7 Breast | 254 / 17959 (1.4%) | 9154 / 179590 (5.1%) | −142.3 | −140.2 | 0.28 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 374 / 17959 (2.1%) | 11158 / 179590 (6.2%) | −142.3 | −140.2 | 0.34 |
| ETS1 SRX3033231 | HEYA8 Gonad | 305 / 17959 (1.7%) | 332 / 179590 (0.2%) | −142.1 | −140.0 | 9.19 |
| FOXA1 SRX3931032 | MCF-7 Breast | 253 / 17959 (1.4%) | 9129 / 179590 (5.1%) | −142.0 | −139.9 | 0.28 |
| ESR1 SRX2881001 | MCF-7 Breast | 234 / 17959 (1.3%) | 8792 / 179590 (4.9%) | −142.0 | −139.9 | 0.27 |
| FOXA1 SRX3923519 | MCF-7 Breast | 266 / 17959 (1.5%) | 9345 / 179590 (5.2%) | −141.8 | −139.7 | 0.28 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 761 / 17959 (4.2%) | 2366 / 179590 (1.3%) | −141.5 | −139.4 | 3.22 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 373 / 17959 (2.1%) | 11114 / 179590 (6.2%) | −141.5 | −139.4 | 0.34 |
| FOXA1 SRX5203303 | MCF-7 Breast | 142 / 17959 (0.8%) | 7051 / 179590 (3.9%) | −141.4 | −139.3 | 0.20 |
| ARID1A SRX5089391 | MCF-7 Breast | 249 / 17959 (1.4%) | 9032 / 179590 (5.0%) | −141.2 | −139.1 | 0.28 |
| ESR1 SRX2513517 | MCF-7 Breast | 299 / 17959 (1.7%) | 9878 / 179590 (5.5%) | −140.9 | −138.9 | 0.30 |
| ARID1A SRX5089388 | MCF-7 Breast | 223 / 17959 (1.2%) | 8559 / 179590 (4.8%) | −140.8 | −138.8 | 0.26 |
| ARID5B SRX3230377 | Hep G2 Liver | 1074 / 17959 (6.0%) | 21176 / 179590 (11.8%) | −140.8 | −138.7 | 0.51 |
| FOXA1 SRX3923511 | MCF-7 Breast | 161 / 17959 (0.9%) | 7407 / 179590 (4.1%) | −140.7 | −138.7 | 0.22 |
| ESR1 SRX2912055 | MCF-7 Breast | 166 / 17959 (0.9%) | 7498 / 179590 (4.2%) | −140.6 | −138.5 | 0.22 |
| RUNX1 SRX2513054 | 293 Kidney | 3090 / 17959 (17.2%) | 19010 / 179590 (10.6%) | −140.5 | −138.4 | 1.63 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1511 / 17959 (8.4%) | 26816 / 179590 (14.9%) | −140.3 | −138.3 | 0.56 |
| NANOG SRX10445309 | Neural crest cells Neural | 241 / 17959 (1.3%) | 8855 / 179590 (4.9%) | −140.2 | −138.1 | 0.27 |
| AR SRX9109113 | MDA-MB-453 Breast | 831 / 17959 (4.6%) | 17844 / 179590 (9.9%) | −140.1 | −138.1 | 0.47 |
| NR3C1 SRX19024866 | MCF-7 Breast | 150 / 17959 (0.8%) | 7169 / 179590 (4.0%) | −140.0 | −137.9 | 0.21 |
| CEBPA SRX2630241 | Hep G2 Liver | 543 / 17959 (3.0%) | 13692 / 179590 (7.6%) | −139.9 | −137.8 | 0.40 |
| ESR1 SRX5323874 | MCF-7 Breast | 258 / 17959 (1.4%) | 9144 / 179590 (5.1%) | −139.8 | −137.8 | 0.28 |
| FOXA1 SRX5323846 | MCF-7 Breast | 163 / 17959 (0.9%) | 7410 / 179590 (4.1%) | −139.7 | −137.6 | 0.22 |
| ESR1 SRX10365534 | MCF-7 Breast | 128 / 17959 (0.7%) | 6710 / 179590 (3.7%) | −139.3 | −137.2 | 0.19 |
| ESR1 SRX2513520 | MCF-7 Breast | 277 / 17959 (1.5%) | 9447 / 179590 (5.3%) | −139.1 | −137.0 | 0.29 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 396 / 17959 (2.2%) | 11375 / 179590 (6.3%) | −138.3 | −136.3 | 0.35 |
| FOXA1 SRX5323829 | T-47D Breast | 253 / 17959 (1.4%) | 9005 / 179590 (5.0%) | −138.3 | −136.3 | 0.28 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 224 / 17959 (1.2%) | 8496 / 179590 (4.7%) | −138.3 | −136.3 | 0.26 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 567 / 17959 (3.2%) | 13989 / 179590 (7.8%) | −138.3 | −136.2 | 0.41 |
| ESR1 SRX792933 | LY2 Breast | 371 / 17959 (2.1%) | 10948 / 179590 (6.1%) | −137.6 | −135.5 | 0.34 |
| FOXA1 SRX100477 | Hep G2 Liver | 508 / 17959 (2.8%) | 13070 / 179590 (7.3%) | −137.3 | −135.3 | 0.39 |
| NR3C1 SRX8520802 | HCC1187 Breast | 326 / 17959 (1.8%) | 10201 / 179590 (5.7%) | −137.1 | −135.1 | 0.32 |
| EP300 SRX1012643 | MCF-7 Breast | 163 / 17959 (0.9%) | 7333 / 179590 (4.1%) | −137.1 | −135.0 | 0.22 |
| SOX13 SRX2636248 | Hep G2 Liver | 614 / 17959 (3.4%) | 14630 / 179590 (8.1%) | −137.1 | −135.0 | 0.42 |
| ZEB1 SRX13298925 | MCF-7 Breast | 279 / 17959 (1.6%) | 9405 / 179590 (5.2%) | −136.8 | −134.7 | 0.30 |
| SS18 SRX3468047 | Fibroblasts Others | 1097 / 17959 (6.1%) | 21298 / 179590 (11.9%) | −136.7 | −134.6 | 0.52 |
| 5-mC SRX882968 | LNCAP Prostate | 2703 / 17959 (15.1%) | 16067 / 179590 (8.9%) | −136.4 | −134.3 | 1.68 |
| FOXA1 SRX5323830 | T-47D Breast | 269 / 17959 (1.5%) | 9217 / 179590 (5.1%) | −136.3 | −134.2 | 0.29 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 863 / 17959 (4.8%) | 18112 / 179590 (10.1%) | −136.0 | −134.0 | 0.48 |
| ESR1 SRX1469951 | MCF-7 Breast | 232 / 17959 (1.3%) | 8564 / 179590 (4.8%) | −136.0 | −134.0 | 0.27 |
| FOXA1 SRX5323845 | MCF-7 Breast | 164 / 17959 (0.9%) | 7321 / 179590 (4.1%) | −135.9 | −133.9 | 0.22 |
| ESR1 SRX5323876 | MCF-7 Breast | 236 / 17959 (1.3%) | 8630 / 179590 (4.8%) | −135.8 | −133.8 | 0.27 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1955 / 17959 (10.9%) | 10363 / 179590 (5.8%) | −135.8 | −133.8 | 1.89 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 259 / 17959 (1.4%) | 9024 / 179590 (5.0%) | −135.7 | −133.6 | 0.29 |
| TET2 SRX8617001 | MCF-7 Breast | 299 / 17959 (1.7%) | 9700 / 179590 (5.4%) | −135.5 | −133.5 | 0.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 305 / 17959 (1.7%) | 9794 / 179590 (5.5%) | −135.4 | −133.3 | 0.31 |
| NR3C1 SRX19024870 | MCF-7 Breast | 148 / 17959 (0.8%) | 6995 / 179590 (3.9%) | −135.3 | −133.3 | 0.21 |
| ESR1 SRX1012625 | MCF-7 Breast | 234 / 17959 (1.3%) | 8580 / 179590 (4.8%) | −135.3 | −133.3 | 0.27 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 297 / 17959 (1.7%) | 9649 / 179590 (5.4%) | −135.0 | −133.0 | 0.31 |
| TFAP2C SRX018833 | MCF-7 Breast | 408 / 17959 (2.3%) | 11446 / 179590 (6.4%) | −135.0 | −133.0 | 0.36 |
| CEBPB SRX150632 | HeLa Uterus | 997 / 17959 (5.6%) | 19885 / 179590 (11.1%) | −134.9 | −132.9 | 0.50 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1633 / 17959 (9.1%) | 28066 / 179590 (15.6%) | −134.6 | −132.6 | 0.58 |
| ESR1 SRX1012630 | MCF-7 Breast | 174 / 17959 (1.0%) | 7464 / 179590 (4.2%) | −134.5 | −132.5 | 0.23 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 175 / 17959 (1.0%) | 7481 / 179590 (4.2%) | −134.4 | −132.4 | 0.23 |
| TFAP2C SRX128099 | MCF-7 Breast | 409 / 17959 (2.3%) | 11426 / 179590 (6.4%) | −134.1 | −132.1 | 0.36 |
| ESR1 SRX3123823 | MCF-7 Breast | 154 / 17959 (0.9%) | 7063 / 179590 (3.9%) | −133.9 | −131.8 | 0.22 |
| ESR1 SRX2513521 | MCF-7 Breast | 218 / 17959 (1.2%) | 8223 / 179590 (4.6%) | −133.2 | −131.1 | 0.27 |
| ESR1 SRX1012628 | MCF-7 Breast | 234 / 17959 (1.3%) | 8491 / 179590 (4.7%) | −132.6 | −130.6 | 0.28 |
| EP300 SRX176883 | MCF-7 Breast | 216 / 17959 (1.2%) | 8164 / 179590 (4.5%) | −132.4 | −130.4 | 0.26 |
| FOXA1 SRX1161205 | T-47D Breast | 247 / 17959 (1.4%) | 8710 / 179590 (4.8%) | −132.3 | −130.3 | 0.28 |
| CBX3 SRX6712570 | MCF-7 Breast | 361 / 17959 (2.0%) | 10604 / 179590 (5.9%) | −132.3 | −130.3 | 0.34 |
| FOXA1 SRX5203307 | MCF-7 Breast | 133 / 17959 (0.7%) | 6605 / 179590 (3.7%) | −132.2 | −130.2 | 0.20 |
| KAT7 DRX300414 | 293 Kidney | 605 / 17959 (3.4%) | 1654 / 179590 (0.9%) | −132.2 | −130.2 | 3.66 |
| ESR1 SRX20282966 | MCF-7 Breast | 162 / 17959 (0.9%) | 7154 / 179590 (4.0%) | −131.8 | −129.8 | 0.23 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 350 / 17959 (1.9%) | 10405 / 179590 (5.8%) | −131.7 | −129.7 | 0.34 |
| VGLL1 SRX18013277 | FULVR Breast | 198 / 17959 (1.1%) | 7816 / 179590 (4.4%) | −131.6 | −129.6 | 0.25 |
| ESR1 SRX1995230 | MCF-7 Breast | 389 / 17959 (2.2%) | 11018 / 179590 (6.1%) | −131.5 | −129.5 | 0.35 |
| NR3C1 SRX2609664 | HASM2 Lung | 636 / 17959 (3.5%) | 14722 / 179590 (8.2%) | −131.3 | −129.3 | 0.43 |
| FOXA1 SRX1447316 | MCF-7 Breast | 198 / 17959 (1.1%) | 7788 / 179590 (4.3%) | −130.7 | −128.7 | 0.25 |
| ESR1 SRX4451214 | MCF-7 Breast | 406 / 17959 (2.3%) | 11259 / 179590 (6.3%) | −130.7 | −128.7 | 0.36 |
| GATA3 SRX100559 | T-47D Breast | 515 / 17959 (2.9%) | 12917 / 179590 (7.2%) | −130.5 | −128.5 | 0.40 |
| GATA3 SRX190194 | SK-N-SH Neural | 1059 / 17959 (5.9%) | 20501 / 179590 (11.4%) | −130.3 | −128.3 | 0.52 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 134 / 17959 (0.7%) | 6570 / 179590 (3.7%) | −130.3 | −128.3 | 0.20 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 710 / 17959 (4.0%) | 2231 / 179590 (1.2%) | −130.1 | −128.1 | 3.18 |
| GATAD2A SRX2636506 | Hep G2 Liver | 593 / 17959 (3.3%) | 14048 / 179590 (7.8%) | −130.0 | −128.0 | 0.42 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 327 / 17959 (1.8%) | 9968 / 179590 (5.6%) | −129.9 | −127.9 | 0.33 |
| ESR1 SRX176856 | MCF-7 Breast | 157 / 17959 (0.9%) | 6994 / 179590 (3.9%) | −129.7 | −127.7 | 0.22 |
| SMARCA2 SRX8119677 | MeT-5A Others | 751 / 17959 (4.2%) | 16286 / 179590 (9.1%) | −129.6 | −127.6 | 0.46 |
| ESR1 SRX5287697 | MCF-7 Breast | 170 / 17959 (0.9%) | 7226 / 179590 (4.0%) | −129.2 | −127.2 | 0.24 |
| ARID5B SRX10475139 | Hep G2 Liver | 507 / 17959 (2.8%) | 12741 / 179590 (7.1%) | −129.0 | −127.0 | 0.40 |
| ESR1 SRX1012631 | MCF-7 Breast | 206 / 17959 (1.1%) | 7878 / 179590 (4.4%) | −128.9 | −126.9 | 0.26 |
| FOXA1 SRX5203294 | MCF-7 Breast | 133 / 17959 (0.7%) | 6505 / 179590 (3.6%) | −128.9 | −126.9 | 0.20 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 549 / 17959 (3.1%) | 13354 / 179590 (7.4%) | −128.7 | −126.8 | 0.41 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1072 / 17959 (6.0%) | 20603 / 179590 (11.5%) | −128.7 | −126.8 | 0.52 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 489 / 17959 (2.7%) | 12447 / 179590 (6.9%) | −128.5 | −126.5 | 0.39 |
| PROX1 SRX3230397 | Hep G2 Liver | 343 / 17959 (1.9%) | 10169 / 179590 (5.7%) | −128.2 | −126.2 | 0.34 |
| FOXA1 SRX1787654 | MCF-7 Breast | 176 / 17959 (1.0%) | 7304 / 179590 (4.1%) | −128.1 | −126.1 | 0.24 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 292 / 17959 (1.6%) | 9324 / 179590 (5.2%) | −128.0 | −126.0 | 0.31 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 483 / 17959 (2.7%) | 12336 / 179590 (6.9%) | −127.9 | −125.9 | 0.39 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 312 / 17959 (1.7%) | 9650 / 179590 (5.4%) | −127.8 | −125.8 | 0.32 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1367 / 17959 (7.6%) | 6382 / 179590 (3.6%) | −127.5 | −125.6 | 2.14 |
| FOS SRX4192880 | MCF 10A Breast | 809 / 17959 (4.5%) | 17006 / 179590 (9.5%) | −127.5 | −125.5 | 0.48 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 179 / 17959 (1.0%) | 7341 / 179590 (4.1%) | −127.4 | −125.5 | 0.24 |
| FOXA1 SRX15431000 | T-47D Breast | 388 / 17959 (2.2%) | 10845 / 179590 (6.0%) | −127.1 | −125.2 | 0.36 |
| FOXA1 SRX9604647 | LNCAP Prostate | 698 / 17959 (3.9%) | 15423 / 179590 (8.6%) | −126.7 | −124.7 | 0.45 |
| FOXA1 SRX6860635 | T-47D Breast | 362 / 17959 (2.0%) | 10420 / 179590 (5.8%) | −126.7 | −124.7 | 0.35 |
| ING2 SRX286201 | RKO Digestive tract | 1365 / 17959 (7.6%) | 6391 / 179590 (3.6%) | −126.5 | −124.6 | 2.14 |
| ESR1 SRX3110720 | MCF-7 Breast | 198 / 17959 (1.1%) | 7654 / 179590 (4.3%) | −126.5 | −124.5 | 0.26 |
| FOXA1 SRX3931031 | MCF-7 Breast | 228 / 17959 (1.3%) | 8173 / 179590 (4.6%) | −126.1 | −124.1 | 0.28 |
| 5-mC SRX882965 | LNCAP Prostate | 2205 / 17959 (12.3%) | 12541 / 179590 (7.0%) | −125.9 | −123.9 | 1.76 |
| KMT2C SRX1787675 | MCF-7 Breast | 423 / 17959 (2.4%) | 11342 / 179590 (6.3%) | −125.8 | −123.8 | 0.37 |
| NCOA3 SRX4663589 | MCF-7 Breast | 134 / 17959 (0.7%) | 6435 / 179590 (3.6%) | −125.7 | −123.7 | 0.21 |
| AHR SRX20282969 | MCF-7 Breast | 222 / 17959 (1.2%) | 8048 / 179590 (4.5%) | −125.5 | −123.5 | 0.28 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1636 / 17959 (9.1%) | 8321 / 179590 (4.6%) | −125.4 | −123.4 | 1.97 |
| TCF12 SRX190356 | SK-N-SH Neural | 1219 / 17959 (6.8%) | 22361 / 179590 (12.5%) | −125.3 | −123.4 | 0.55 |
| GATA3 SRX5457550 | MCF-7 Breast | 541 / 17959 (3.0%) | 13100 / 179590 (7.3%) | −125.3 | −123.3 | 0.41 |
| CEBPB SRX190345 | MCF-7 Breast | 365 / 17959 (2.0%) | 10417 / 179590 (5.8%) | −125.2 | −123.3 | 0.35 |
| JADE3 DRX300415 | 293 Kidney | 1463 / 17959 (8.1%) | 7100 / 179590 (4.0%) | −125.1 | −123.2 | 2.06 |
| JADE3 DRX234809 | 293 Kidney | 985 / 17959 (5.5%) | 3925 / 179590 (2.2%) | −124.9 | −123.0 | 2.51 |
| VGLL1 SRX24602130 | BT-20 Breast | 502 / 17959 (2.8%) | 12507 / 179590 (7.0%) | −124.9 | −123.0 | 0.40 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 513 / 17959 (2.9%) | 12671 / 179590 (7.1%) | −124.8 | −122.9 | 0.40 |
| AR SRX15946405 | MDA-MB-453 Breast | 305 / 17959 (1.7%) | 9435 / 179590 (5.3%) | −124.8 | −122.9 | 0.32 |
| STAT3 SRX2020842 | HCC70 Breast | 816 / 17959 (4.5%) | 16983 / 179590 (9.5%) | −124.7 | −122.8 | 0.48 |
| HMG20A SRX2630163 | Hep G2 Liver | 274 / 17959 (1.5%) | 8904 / 179590 (5.0%) | −124.4 | −122.5 | 0.31 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 244 / 17959 (1.4%) | 8382 / 179590 (4.7%) | −124.0 | −122.0 | 0.29 |
| Epitope tags SRX10549777 | K-562 Blood | 2372 / 17959 (13.2%) | 13896 / 179590 (7.7%) | −124.0 | −122.0 | 1.71 |
| AR SRX11149848 | MDA-MB-453 Breast | 307 / 17959 (1.7%) | 9438 / 179590 (5.3%) | −124.0 | −122.0 | 0.33 |
| ESR1 SRX5089450 | MCF-7 Breast | 261 / 17959 (1.5%) | 8666 / 179590 (4.8%) | −123.8 | −121.9 | 0.30 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 205 / 17959 (1.1%) | 7697 / 179590 (4.3%) | −123.8 | −121.8 | 0.27 |
| FOXA1 SRX3923510 | MCF-7 Breast | 185 / 17959 (1.0%) | 7328 / 179590 (4.1%) | −123.5 | −121.6 | 0.25 |
| FOXA1 SRX6878604 | LNCAP Prostate | 389 / 17959 (2.2%) | 10732 / 179590 (6.0%) | −123.5 | −121.5 | 0.36 |
| EP300 ERX626821 | U-937 Blood | 1177 / 17959 (6.6%) | 5190 / 179590 (2.9%) | −123.4 | −121.5 | 2.27 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 192 / 17959 (1.1%) | 102 / 179590 (0.1%) | −123.4 | −121.5 | 18.82 |
| MLLT6 DRX059637 | 293 Kidney | 384 / 17959 (2.1%) | 714 / 179590 (0.4%) | −123.4 | −121.4 | 5.38 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 471 / 17959 (2.6%) | 11971 / 179590 (6.7%) | −123.1 | −121.1 | 0.39 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 239 / 17959 (1.3%) | 8267 / 179590 (4.6%) | −123.1 | −121.1 | 0.29 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 187 / 17959 (1.0%) | 93 / 179590 (0.1%) | −122.9 | −121.0 | 20.11 |
| ESR1 SRX2513519 | MCF-7 Breast | 266 / 17959 (1.5%) | 8718 / 179590 (4.9%) | −122.8 | −120.9 | 0.31 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 413 / 17959 (2.3%) | 11076 / 179590 (6.2%) | −122.8 | −120.9 | 0.37 |
| PGR SRX3990986 | T-47D Breast | 414 / 17959 (2.3%) | 11085 / 179590 (6.2%) | −122.5 | −120.6 | 0.37 |
| FOXA1 SRX3931073 | MCF-7 Breast | 285 / 17959 (1.6%) | 9025 / 179590 (5.0%) | −122.5 | −120.6 | 0.32 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 143 / 17959 (0.8%) | 6510 / 179590 (3.6%) | −122.4 | −120.5 | 0.22 |
| AR SRX1067066 | LHSAR Prostate | 963 / 17959 (5.4%) | 18864 / 179590 (10.5%) | −122.3 | −120.3 | 0.51 |
| AR SRX9469987 | LAPC-4 Prostate | 231 / 17959 (1.3%) | 8104 / 179590 (4.5%) | −122.2 | −120.3 | 0.29 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 142 / 17959 (0.8%) | 6478 / 179590 (3.6%) | −122.1 | −120.1 | 0.22 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 302 / 17959 (1.7%) | 9290 / 179590 (5.2%) | −122.0 | −120.1 | 0.33 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 357 / 17959 (2.0%) | 616 / 179590 (0.3%) | −122.0 | −120.1 | 5.80 |
| ESR1 SRX3123830 | MCF-7 Breast | 138 / 17959 (0.8%) | 6396 / 179590 (3.6%) | −121.8 | −119.9 | 0.22 |
| MAU2 SRX11120892 | MCF-7 Breast | 209 / 17959 (1.2%) | 7706 / 179590 (4.3%) | −121.8 | −119.9 | 0.27 |
| ESR1 SRX968963 | MCF-7 Breast | 199 / 17959 (1.1%) | 7526 / 179590 (4.2%) | −121.8 | −119.9 | 0.26 |
| ESR1 SRX1469950 | MCF-7 Breast | 181 / 17959 (1.0%) | 7192 / 179590 (4.0%) | −121.6 | −119.7 | 0.25 |
| ARID5B SRX10475138 | Hep G2 Liver | 779 / 17959 (4.3%) | 16336 / 179590 (9.1%) | −121.6 | −119.7 | 0.48 |
| FOXA2 SRX10475773 | Hep G2 Liver | 583 / 17959 (3.2%) | 13570 / 179590 (7.6%) | −121.6 | −119.7 | 0.43 |
| EP300 ERX626811 | U-937 Blood | 1173 / 17959 (6.5%) | 5202 / 179590 (2.9%) | −121.6 | −119.6 | 2.25 |
| FOXA1 SRX15391842 | T-47D Breast | 273 / 17959 (1.5%) | 8792 / 179590 (4.9%) | −121.6 | −119.6 | 0.31 |
| SOX5 SRX2636544 | Hep G2 Liver | 481 / 17959 (2.7%) | 12058 / 179590 (6.7%) | −121.3 | −119.4 | 0.40 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1276 / 17959 (7.1%) | 5908 / 179590 (3.3%) | −120.9 | −118.9 | 2.16 |
| FOXA1 SRX1161207 | T-47D Breast | 209 / 17959 (1.2%) | 7673 / 179590 (4.3%) | −120.8 | −118.9 | 0.27 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 165 / 17959 (0.9%) | 6871 / 179590 (3.8%) | −120.7 | −118.8 | 0.24 |
| FOXA1 SRX3923508 | MCF-7 Breast | 158 / 17959 (0.9%) | 6737 / 179590 (3.8%) | −120.7 | −118.7 | 0.23 |
| GATAD2A SRX2636507 | Hep G2 Liver | 522 / 17959 (2.9%) | 12639 / 179590 (7.0%) | −120.6 | −118.7 | 0.41 |
| ESR1 SRX2513518 | MCF-7 Breast | 245 / 17959 (1.4%) | 8284 / 179590 (4.6%) | −120.5 | −118.5 | 0.30 |
| FOXA1 SRX9550932 | Prostate cancer Prostate | 575 / 17959 (3.2%) | 13406 / 179590 (7.5%) | −120.4 | −118.5 | 0.43 |
| JUNB SRX8488088 | SUM 229PE Breast | 914 / 17959 (5.1%) | 18116 / 179590 (10.1%) | −120.3 | −118.4 | 0.50 |
| ESR1 SRX8537718 | SUM 44PE Breast | 291 / 17959 (1.6%) | 9051 / 179590 (5.0%) | −120.3 | −118.4 | 0.32 |
| KMT2A SRX2323891 | 293 Kidney | 920 / 17959 (5.1%) | 3600 / 179590 (2.0%) | −120.2 | −118.3 | 2.56 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 330 / 17959 (1.8%) | 9680 / 179590 (5.4%) | −120.2 | −118.3 | 0.34 |
| FOXA1 SRX10306473 | T-47D Breast | 208 / 17959 (1.2%) | 7619 / 179590 (4.2%) | −119.8 | −117.9 | 0.27 |
| FOXA1 SRX1161172 | MCF-7 Breast | 490 / 17959 (2.7%) | 12132 / 179590 (6.8%) | −119.7 | −117.8 | 0.40 |
| MAU2 SRX11120893 | MCF-7 Breast | 206 / 17959 (1.1%) | 7584 / 179590 (4.2%) | −119.7 | −117.8 | 0.27 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1458 / 17959 (8.1%) | 7199 / 179590 (4.0%) | −119.7 | −117.8 | 2.03 |
| ARID1A SRX5089380 | MCF-7 Breast | 188 / 17959 (1.0%) | 7256 / 179590 (4.0%) | −119.6 | −117.7 | 0.26 |
| ESR1 SRX5534832 | MCF-7 Breast | 448 / 17959 (2.5%) | 11489 / 179590 (6.4%) | −119.5 | −117.6 | 0.39 |
| STAT3 SRX5323860 | MCF-7 Breast | 604 / 17959 (3.4%) | 13789 / 179590 (7.7%) | −119.5 | −117.6 | 0.44 |
| ESR1 SRX1585242 | MCF-7 Breast | 187 / 17959 (1.0%) | 7237 / 179590 (4.0%) | −119.5 | −117.6 | 0.26 |
| FOXA1 SRX219284 | LNCAP Prostate | 643 / 17959 (3.6%) | 14339 / 179590 (8.0%) | −119.4 | −117.5 | 0.45 |
| FOS SRX150517 | MCF 10A Breast | 833 / 17959 (4.6%) | 16980 / 179590 (9.5%) | −119.3 | −117.4 | 0.49 |
| MEN1 SRX11712604 | K-562 Blood | 1337 / 17959 (7.4%) | 6363 / 179590 (3.5%) | −119.2 | −117.3 | 2.10 |
| PGR SRX3990996 | T-47D Breast | 478 / 17959 (2.7%) | 11930 / 179590 (6.6%) | −119.2 | −117.3 | 0.40 |
| LARP7 SRX2198835 | HeLa Uterus | 2022 / 17959 (11.3%) | 11366 / 179590 (6.3%) | −118.9 | −117.0 | 1.78 |
| ESR1 SRX7624162 | T-47D Breast | 284 / 17959 (1.6%) | 8884 / 179590 (4.9%) | −118.8 | −116.9 | 0.32 |
| ESR1 SRX20282967 | MCF-7 Breast | 153 / 17959 (0.9%) | 6585 / 179590 (3.7%) | −118.7 | −116.8 | 0.23 |
| AHR SRX2378695 | MCF-7 Breast | 217 / 17959 (1.2%) | 7735 / 179590 (4.3%) | −118.5 | −116.6 | 0.28 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1017 / 17959 (5.7%) | 4244 / 179590 (2.4%) | −118.4 | −116.5 | 2.40 |
| FOXA1 SRX190282 | A549 Lung | 353 / 17959 (2.0%) | 9980 / 179590 (5.6%) | −118.3 | −116.4 | 0.35 |
| SP1 SRX5457499 | Liver Liver | 821 / 17959 (4.6%) | 16764 / 179590 (9.3%) | −118.2 | −116.3 | 0.49 |
| FOXA1 SRX2642368 | VCaP Prostate | 587 / 17959 (3.3%) | 13479 / 179590 (7.5%) | −117.9 | −116.0 | 0.44 |
| FOXA1 SRX8537737 | MCF-7 Breast | 197 / 17959 (1.1%) | 7360 / 179590 (4.1%) | −117.8 | −115.9 | 0.27 |
| FOXA1 SRX3923509 | MCF-7 Breast | 148 / 17959 (0.8%) | 6454 / 179590 (3.6%) | −117.5 | −115.6 | 0.23 |
| ESR1 SRX5323875 | MCF-7 Breast | 187 / 17959 (1.0%) | 7170 / 179590 (4.0%) | −117.5 | −115.6 | 0.26 |
| NR3C1 SRX1161167 | MCF-7 Breast | 137 / 17959 (0.8%) | 6243 / 179590 (3.5%) | −117.4 | −115.6 | 0.22 |
| CDK9 SRX7366779 | MCF-7 Breast | 196 / 17959 (1.1%) | 126 / 179590 (0.1%) | −117.4 | −115.5 | 15.56 |
| ESR1 SRX3554403 | MDA-MB-134-VI Breast | 224 / 17959 (1.2%) | 7817 / 179590 (4.4%) | −117.3 | −115.5 | 0.29 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 902 / 17959 (5.0%) | 17821 / 179590 (9.9%) | −117.3 | −115.4 | 0.51 |
| ZEB1 SRX13298923 | MCF-7 Breast | 219 / 17959 (1.2%) | 7730 / 179590 (4.3%) | −117.3 | −115.4 | 0.28 |
| NR3C1 SRX19024880 | MCF-7 Breast | 136 / 17959 (0.8%) | 6214 / 179590 (3.5%) | −117.1 | −115.2 | 0.22 |
| ESR1 SRX9719167 | MCF-7 Breast | 232 / 17959 (1.3%) | 7948 / 179590 (4.4%) | −117.0 | −115.1 | 0.29 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 587 / 17959 (3.3%) | 13439 / 179590 (7.5%) | −116.9 | −115.0 | 0.44 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 411 / 17959 (2.3%) | 10821 / 179590 (6.0%) | −116.6 | −114.8 | 0.38 |
| FOXA1 SRX1961163 | T-47D Breast | 330 / 17959 (1.8%) | 9546 / 179590 (5.3%) | −116.5 | −114.6 | 0.35 |
| STAT1 SRX23678708 | K-562 Blood | 1447 / 17959 (8.1%) | 7201 / 179590 (4.0%) | −116.4 | −114.5 | 2.01 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 660 / 17959 (3.7%) | 14458 / 179590 (8.1%) | −116.4 | −114.5 | 0.46 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 645 / 17959 (3.6%) | 14243 / 179590 (7.9%) | −116.4 | −114.5 | 0.45 |
| FOXA2 SRX14524990 | hESC derived pancreatic cells Pluripotent stem cell | 766 / 17959 (4.3%) | 15928 / 179590 (8.9%) | −116.3 | −114.4 | 0.48 |
| VGLL1 SRX18013278 | FULVR Breast | 249 / 17959 (1.4%) | 8201 / 179590 (4.6%) | −116.0 | −114.2 | 0.30 |
| FOXA1 SRX5323844 | MCF-7 Breast | 148 / 17959 (0.8%) | 6407 / 179590 (3.6%) | −116.0 | −114.1 | 0.23 |
| ESR1 SRX371446 | Tumour tissues Others | 513 / 17959 (2.9%) | 12326 / 179590 (6.9%) | −116.0 | −114.1 | 0.42 |
| FOXA1 SRX190181 | A549 Lung | 371 / 17959 (2.1%) | 10169 / 179590 (5.7%) | −115.8 | −114.0 | 0.36 |
| PGR SRX3990984 | T-47D Breast | 459 / 17959 (2.6%) | 11515 / 179590 (6.4%) | −115.8 | −113.9 | 0.40 |
| FOXA1 SRX9604645 | LNCAP Prostate | 678 / 17959 (3.8%) | 14681 / 179590 (8.2%) | −115.7 | −113.8 | 0.46 |
| NR3C1 SRX2609665 | HASM2 Lung | 546 / 17959 (3.0%) | 12792 / 179590 (7.1%) | −115.6 | −113.8 | 0.43 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 193 / 17959 (1.1%) | 7216 / 179590 (4.0%) | −115.5 | −113.7 | 0.27 |
| TET2 SRX8617003 | MCF-7 Breast | 170 / 17959 (0.9%) | 6801 / 179590 (3.8%) | −115.5 | −113.6 | 0.25 |
| FOXA1 SRX8537736 | MCF-7 Breast | 186 / 17959 (1.0%) | 7093 / 179590 (3.9%) | −115.5 | −113.6 | 0.26 |
| ARID1A SRX5089381 | MCF-7 Breast | 208 / 17959 (1.2%) | 7474 / 179590 (4.2%) | −115.4 | −113.5 | 0.28 |
| ESR1 SRX5089447 | MCF-7 Breast | 240 / 17959 (1.3%) | 8029 / 179590 (4.5%) | −115.3 | −113.5 | 0.30 |
| FOXA1 SRX12971647 | Prostatic Neoplasms, Castration-Resistant Prostate | 350 / 17959 (1.9%) | 9823 / 179590 (5.5%) | −115.3 | −113.5 | 0.36 |
| FOXA1 SRX9550931 | Prostate cancer Prostate | 350 / 17959 (1.9%) | 9823 / 179590 (5.5%) | −115.3 | −113.5 | 0.36 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 832 / 17959 (4.6%) | 16788 / 179590 (9.3%) | −115.3 | −113.5 | 0.50 |
| ESR1 SRX3080213 | MCF-7 Breast | 135 / 17959 (0.8%) | 6137 / 179590 (3.4%) | −115.2 | −113.4 | 0.22 |
| Epitope tags SRX5877912 | U2OS Bone | 2449 / 17959 (13.6%) | 36803 / 179590 (20.5%) | −115.0 | −113.1 | 0.67 |
| FOXA1 SRX9550928 | Prostate cancer Prostate | 615 / 17959 (3.4%) | 13747 / 179590 (7.7%) | −114.6 | −112.8 | 0.45 |
| ESR1 SRX176858 | MCF-7 Breast | 175 / 17959 (1.0%) | 6862 / 179590 (3.8%) | −114.6 | −112.7 | 0.26 |
| DOT1L DRX411731 | 293 Kidney | 265 / 17959 (1.5%) | 329 / 179590 (0.2%) | −114.3 | −112.4 | 8.05 |
| NR3C1 SRX2609662 | HASM2 Lung | 590 / 17959 (3.3%) | 13374 / 179590 (7.4%) | −114.3 | −112.4 | 0.44 |
| ZEB1 SRX13298924 | MCF-7 Breast | 254 / 17959 (1.4%) | 8228 / 179590 (4.6%) | −114.2 | −112.4 | 0.31 |
| NABP2 SRX9523535 | HT-1080 Bone | 1298 / 17959 (7.2%) | 6213 / 179590 (3.5%) | −114.2 | −112.3 | 2.09 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 612 / 17959 (3.4%) | 1896 / 179590 (1.1%) | −114.1 | −112.3 | 3.23 |
| ESR1 SRX8537719 | SUM 44PE Breast | 316 / 17959 (1.8%) | 9237 / 179590 (5.1%) | −114.1 | −112.2 | 0.34 |
| EP300 SRX2194266 | SUM 159PT Breast | 825 / 17959 (4.6%) | 16637 / 179590 (9.3%) | −114.0 | −112.2 | 0.50 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1134 / 17959 (6.3%) | 20716 / 179590 (11.5%) | −114.0 | −112.1 | 0.55 |
| RBFOX2 SRX4708082 | K-562 Blood | 2241 / 17959 (12.5%) | 13221 / 179590 (7.4%) | −113.8 | −112.0 | 1.70 |
| KDM6A SRX15826236 | MCF-7 Breast | 171 / 17959 (1.0%) | 6764 / 179590 (3.8%) | −113.7 | −111.8 | 0.25 |
| ESR1 SRX2922233 | SUM 44PE Breast | 564 / 17959 (3.1%) | 12970 / 179590 (7.2%) | −113.6 | −111.7 | 0.43 |
| TRPS1 SRX3401273 | MCF-7 Breast | 181 / 17959 (1.0%) | 6934 / 179590 (3.9%) | −113.4 | −111.5 | 0.26 |
| ESR1 SRX2922232 | SUM 44PE Breast | 220 / 17959 (1.2%) | 7608 / 179590 (4.2%) | −113.0 | −111.2 | 0.29 |
| ESR1 SRX7624161 | T-47D Breast | 297 / 17959 (1.7%) | 8886 / 179590 (4.9%) | −112.8 | −111.0 | 0.33 |
| RBM22 SRX4708083 | K-562 Blood | 864 / 17959 (4.8%) | 3381 / 179590 (1.9%) | −112.8 | −110.9 | 2.56 |
| EP300 SRX1012649 | MCF-7 Breast | 172 / 17959 (1.0%) | 6750 / 179590 (3.8%) | −112.8 | −110.9 | 0.25 |
| FOXA1 SRX6860646 | T-47D Breast | 294 / 17959 (1.6%) | 8835 / 179590 (4.9%) | −112.7 | −110.9 | 0.33 |
| FOXA3 SRX2630190 | Hep G2 Liver | 427 / 17959 (2.4%) | 10894 / 179590 (6.1%) | −112.1 | −110.3 | 0.39 |
| AR SRX10365514 | MCF-7 Breast | 124 / 17959 (0.7%) | 5830 / 179590 (3.2%) | −112.1 | −110.3 | 0.21 |
| FOXA1 SRX3923513 | MCF-7 Breast | 164 / 17959 (0.9%) | 6581 / 179590 (3.7%) | −112.0 | −110.2 | 0.25 |
| FOXA1 SRX3931083 | MCF-7 Breast | 307 / 17959 (1.7%) | 8994 / 179590 (5.0%) | −111.3 | −109.4 | 0.34 |
| FOXA1 SRX5323828 | T-47D Breast | 221 / 17959 (1.2%) | 7564 / 179590 (4.2%) | −111.2 | −109.3 | 0.29 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 463 / 17959 (2.6%) | 11393 / 179590 (6.3%) | −111.0 | −109.2 | 0.41 |
| NFIL3 SRX2630334 | Hep G2 Liver | 413 / 17959 (2.3%) | 10636 / 179590 (5.9%) | −111.0 | −109.2 | 0.39 |
| FOXA1 SRX5493758 | Breast cancer cells Breast | 379 / 17959 (2.1%) | 10115 / 179590 (5.6%) | −111.0 | −109.2 | 0.37 |
| VGLL1 SRX18013279 | FULVR Breast | 258 / 17959 (1.4%) | 8179 / 179590 (4.6%) | −110.9 | −109.0 | 0.32 |
| FOXA1 SRX9604646 | LNCAP Prostate | 673 / 17959 (3.7%) | 14403 / 179590 (8.0%) | −110.8 | −109.0 | 0.47 |
| EP300 SRX100544 | Hep G2 Liver | 393 / 17959 (2.2%) | 10327 / 179590 (5.8%) | −110.8 | −109.0 | 0.38 |
| Epitope tags SRX8080552 | Mammary gland ductal carcinoma Breast | 263 / 17959 (1.5%) | 8247 / 179590 (4.6%) | −110.5 | −108.7 | 0.32 |
| CDK9 SRX7366780 | MCF-7 Breast | 181 / 17959 (1.0%) | 111 / 179590 (0.1%) | −110.5 | −108.7 | 16.31 |
| NCOA3 SRX10365550 | MCF-7 Breast | 50 / 17959 (0.3%) | 4203 / 179590 (2.3%) | −110.4 | −108.6 | 0.12 |
Showing first 500 of 23847 rows.